Physician profile
Eugen Ivan
NPI 1790735389
$32,982.15
in general payments reported to CMS, 2019-2025
16 companies · $490 in 2025
The $490 reported for 2025 was more than what 78% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $5,961 · 2021: $8,441 · 2023: $2,566 · 2024: $391 · 2025: $490.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,250 · Food and Beverage: $1,056 · Consulting Fee: $1,000 · Travel and Lodging: $141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,250.00 |
| Food and Beverage | $1,055.73 |
| Consulting Fee | $1,000.00 |
| Travel and Lodging | $141.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $11,403.58 | 2019-2021 | |
| Abbott Laboratories | $6,143.71 | 2021-2025 | Dragonfly Opstar, Optis, Coroflow |
| Pfizer INC. | $5,297.72 | 2019 | |
| Cardinal Health 200 LLC | $5,202.51 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $3,698.45 | 2019-2023 | Eliquis |
| Boston Scientific Corporation | $690.58 | 2019-2025 | Cds Broad Portfolio Offering, Opticross 6, Watchman Flx |
| Asahi Intecc USA, INC. | $180.36 | 2019 | |
| Abiomed | $154.33 | 2021-2025 | Impella |
| Stryker Corporation | $46.00 | 2025 | Triever20 |
| Novartis Pharmaceuticals Corporation | $42.64 | 2021-2023 | |
| Edwards Lifesciences Corporation | $32.29 | 2024 | |
| Surmodics, INC. | $26.23 | 2024 | Pounce Venous Thrombectomy System, Pounce LP Thrombectomy, Pounce Thrombectomy System |
| Shockwave Medical, INC | $23.45 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Portola Pharmaceuticals, LLC | $21.38 | 2020 | |
| Cashflow Solutions, LLC | $18.92 | 2025 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugen Ivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.